دورية أكاديمية

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

التفاصيل البيبلوغرافية
العنوان: A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
المؤلفون: Ademuyiwa, Foluso O.Aff1, IDs41523022005003_cor1, Gao, Feng, Street, Cherease R., Chen, Ina, Northfelt, Donald W., Wesolowski, Robert, Arora, Mili, Brufsky, Adam, Dees, E. Claire, Santa-Maria, Cesar A., Connolly, Roisin M., Force, Jeremy, Moreno-Aspitia, Alvaro, Herndon, John M., Carmody, Madelyn, Davies, Sherri R., Larson, Sarah, Pfaff, Kathleen L., Jones, Stephanie M., Weirather, Jason L., Giobbie-Hurder, Anita, Rodig, Scott J., Liu, Zheng, Hagemann, Ian S., Sharon, Elad, Gillanders, William E.Aff1, IDs41523022005003_cor26
المصدر: npj Breast Cancer. 8(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:23744677
DOI:10.1038/s41523-022-00500-3